Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bio-Techne's Ending Cash Position for the quarter that ended in Mar. 2026 was MXN3,784 Mil.
Bio-Techne's quarterly Ending Cash Position
increased
from Sep. 2025 (MXN2,659 Mil) to Dec. 2025 (MXN3,113 Mil) and
increased
from Dec. 2025 (MXN3,113 Mil) to Mar. 2026 (MXN3,784 Mil).
Bio-Techne's annual Ending Cash Position
declined
from Jun. 2023 (MXN3,096 Mil) to Jun. 2024 (MXN2,781 Mil) but then
increased
from Jun. 2024 (MXN2,781 Mil) to Jun. 2025 (MXN3,054 Mil).
Bio-Techne Ending Cash Position Related Terms
Bio-Techne Ending Cash Position Historical Data
* Premium members only.
The historical data trend for Bio-Techne's Ending Cash Position can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.
Bio-Techne's Ending Cash Position for the fiscal year that ended in Jun. 2025 is calculated as
What does a Ending Cash Position of MXN3,784 Mil mean?
Bio-Techne (MEX:TECH) has a Ending Cash Position of MXN3,784 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Bio-Techne and its competitors.
Is Bio-Techne's Ending Cash Position too high?
Bio-Techne's current Ending Cash Position is MXN3,784 Mil. Overall, Bio-Techne has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Bio-Techne's Ending Cash Position compare to ARWR and CYTK?
Bio-Techne's Ending Cash Position of MXN3,784 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Bio-Techne and its competitors. Bio-Techne's current Ending Cash Position is MXN3,784 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Techne stock overvalued right now?
Bio-Techne (MEX:TECH) has a current Ending Cash Position of MXN3,784 Mil. The stock's GF Value™ is MXN1,103.66, compared to a current price of MXN1,090.00 — trading 1.2% below its estimated fair value. The current Ending Cash Position is MXN3,784 Mil. Bio-Techne's overall GF Score™ is 85/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Bio-Techne (MEX:TECH), the current Ending Cash Position is MXN3,784 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bio-Techne (MEX:TECH) Overvalued in 2026?
Based on GuruFocus' analysis, Bio-Techne stock appears to be undervalued.
The current stock price of MXN1,090.00 is trading 1.2% below its estimated GF Value™ of MXN1,103.66.
Key valuation signals for MEX:TECH:
Ending Cash Position: MXN3,784 Mil
GF Value™: MXN1,103.66 vs. price of MXN1,090.00 (1.2% below fair value)
No single metric tells the full story. See the MEX:TECH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
85GF Score
Get the complete analysis for MEX:TECH
Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:TECH has been successfully added to your 
